Status:
COMPLETED
Epidemiological Survey of Hepatitis D Virus Infection in China
Lead Sponsor:
The First Hospital of Jilin University
Collaborating Sponsors:
Nanfang Hospital, Southern Medical University
The Fourth Affiliated Hospital of Harbin Medical University
Conditions:
Observe and Describe the Prevalence of Hepatitis D Infection Among HBsAg Positive People
Eligibility:
All Genders
16+ years
Brief Summary
This cross-sectional study will screen out hepatitis D virus-infected patients in HBsAg-positive people. Observe and describe the prevalence of hepatitis D infection among HBsAg positive people. The p...
Detailed Description
Entry criteria：1. Age 18 years and above. 2. male or female. 3. Diagnosed as chronic HBV infection (HBsAg positive) 4.Ability to sign informed consent. Exclusion criteria：Patients who disagree to par...
Eligibility Criteria
Inclusion
- Hepatitis B surface antigen or HBV DNA positive
Exclusion
- Can't sign informed consent
Key Trial Info
Start Date :
June 3 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 7 2020
Estimated Enrollment :
5000 Patients enrolled
Trial Details
Trial ID
NCT04483518
Start Date
June 3 2019
End Date
July 7 2020
Last Update
July 23 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
the first hospital of Jilin University
Changchun, Jilin, China, 130021